Skylark Bio

News

Skylark Bio has dosed the first patient in a phase 1/2 trial of SKY-GJB2, a gene therapy for the most common form of genetic deafness in children.

News

In a first for consumer wearables, Google has introduced a feature on Pixel Watch and Fitbit Air devices that it says can monitor insulin resistance.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.